Literature DB >> 7866169

Outbreak of HIV infection in a Scottish prison.

A Taylor1, D Goldberg, J Emslie, J Wrench, L Gruer, S Cameron, J Black, B Davis, J McGregor, E Follett.   

Abstract

OBJECTIVE--To investigate the possible spread of HIV infection and its route of transmission among prison inmates. DESIGN--In response to an outbreak of acute clinical hepatitis B and two seroconversions to HIV infection, counselling and testing for HIV were offered to all inmates over a two week period in July 1993. Information was sought about drug injecting, sexual behaviour, and previous HIV testing. SETTING--HM Prison Glenochil in Scotland. SUBJECTS--Adult male prisoners. MAIN OUTCOME MEASURES--Uptake of HIV counselling and testing; occurrence and mode of HIV transmission within the prison. RESULTS--Of a total 378 inmates, 227 (60%) were counselled and 162 (43%) tested for HIV. Twelve (7%) of those tested were positive for antibody to HIV. One third (76) of those counselled had injected drugs at some time, of whom 33 (43%) had injected in Glenochil; all 12 seropositive men belonged to this latter group. Thirty two of these 33 had shared needles and syringes in the prison. A further two inmates who injected in the prison were diagnosed as positive for HIV two months previously. Evidence based on sequential results and time of entry into prison indicated that eight transmissions definitely occurred within prison in the first half of 1993. CONCLUSION--This is the first report of an outbreak of HIV infection occurring within a prison. Restricted access to injecting equipment resulted in random sharing and placed injectors at high risk of becoming infected with HIV. Measures to prevent further spread of infection among prison injectors are urgently required.

Entities:  

Mesh:

Year:  1995        PMID: 7866169      PMCID: PMC2548692          DOI: 10.1136/bmj.310.6975.289

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

1.  Seroepidemiology of HIV-1 infection in a Catalonian penitentiary.

Authors:  V Martin; J M Bayas; A Laliga; T Pumarola; J Vidal; M T Jiménez de Anta; L Salleras
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

2.  Primary HIV infection: host responses and intervention strategies.

Authors:  B Tindall; D A Cooper
Journal:  AIDS       Date:  1991-01       Impact factor: 4.177

3.  Drug misuse and sharing of needles in Scottish prisons.

Authors:  D H Kennedy; G Nair; L Elliott; J Ditton
Journal:  BMJ       Date:  1991-06-22

4.  Intravenous drug misuse among prison inmates: implications for spread of HIV.

Authors:  S Dye; C Isaacs
Journal:  BMJ       Date:  1991-06-22

5.  AIDS in prison.

Authors:  T W Harding
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

6.  Low and stable prevalence of HIV among drug injectors in Glasgow.

Authors:  A Taylor; M Frischer; S T Green; D Goldberg; N McKeganey; L Gruer
Journal:  Int J STD AIDS       Date:  1994 Mar-Apr       Impact factor: 1.359

7.  Seroconversion to human immunodeficiency virus in prison inmates.

Authors:  C R Horsburgh; J Q Jarvis; T McArther; T Ignacio; P Stock
Journal:  Am J Public Health       Date:  1990-02       Impact factor: 9.308

8.  HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.

Authors:  K I Käll; R G Olin
Journal:  AIDS       Date:  1990-02       Impact factor: 4.177

9.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Moudgil; R D Meyer; D D Ho
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Risk behaviours for HIV infection among drug users in prison.

Authors:  A L Carvell; G J Hart
Journal:  BMJ       Date:  1990-05-26
View more
  41 in total

1.  Criminalisation of HIV transmission: implications for public health in Scotland.

Authors:  S M Bird; A J Brown
Journal:  BMJ       Date:  2001-11-17

2.  Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study.

Authors:  Aumphornpun Buavirat; Kimberly Page-Shafer; G J P van Griensven; J S Mandel; J Evans; J Chuaratanaphong; S Chiamwongpat; R Sacks; A Moss
Journal:  BMJ       Date:  2003-02-08

3.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

Review 4.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 5.  Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system.

Authors:  Kim M Blankenship; Amy B Smoyer; Sarah J Bray; Kristin Mattocks
Journal:  J Health Care Poor Underserved       Date:  2005-11

Review 6.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

7.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

8.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

9.  Provision of syringes: the cutting edge of harm reduction in prison?

Authors:  J Nelles; A Fuhrer; H Hirsbrunner; T Harding
Journal:  BMJ       Date:  1998-07-25

10.  HIV infection among family planning clinic attenders in Glasgow: why prevalence has remained low in this general population group.

Authors:  D Goldberg; S Carr; S Cameron; G Codere
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.